979 results on '"Marcocci, C"'
Search Results
52. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism
53. Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
54. Rare diseases in clinical endocrinology: a taxonomic classification system
55. An altered state of consciousness while using anticoagulants and the incidental discovery of a pituitary lesion: considering pituitary apoplexy
56. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism
57. Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB)
58. Lateral wall orbital decompression in Graves’ orbitopathy
59. Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study
60. Renal complications and quality of life in postsurgical hypoparathyroidism: a case–control study
61. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
62. Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene
63. Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?
64. Hypercalcemia
65. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
66. Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling
67. Update on the use of cinacalcet in the management of primary hyperparathyroidism
68. High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: A preliminary experience
69. Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects
70. Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid
71. Glucocorticoid administration for Graves’ hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association
72. Supplement to: Selenium and the course of mild Gravesʼ orbitopathy.
73. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures
74. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment
75. Graves’ hyperthyroidism of recent onset and Graves’ orbitopathy: To ablate or not to ablate the thyroid?
76. Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice
77. The impact of thyroidectomy on parathyroid glands: A biochemical and clinical profile
78. Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidism
79. Functional Characterization of Four Mutations of the Calcium Sensing Receptor Gene Identified in Patients with Familial Hypocalciuric Hypercalcemia Type 1
80. A large functioning parathyroid lipoadenoma
81. An update on medical management of Graves’ ophthalmopathy
82. Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves’ ophthalmopathy
83. Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves
84. Growth hormone secretion in primary and secondary hyperparathyroidism
85. Spontaneous short-term remission of primary hyperparathyroidism from infarction of a parathyroid adenoma
86. A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors
87. Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: The hypothesis of Kriss revisited
88. Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): Evidence for a role of RAP in the Tg biosynthetic pathway
89. Orbital radiotherapy for Graves’ ophthalmopathy: Useful or useless? Safe or dangerous?
90. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism
91. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism
92. Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)
93. Increased prevalence of primary hyperparathyroidism in treated breast cancer
94. Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Gravesʼ Orbitopathy
95. Highlights
96. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
97. Magnitude and Impact of Osteoporosis and Fractures
98. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues
99. Proteomic analysis of parathyroid glands as potential tool to identified cancer biomarkers: YSF-15
100. Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.